HB Reavis’ Metronom Business Center has secured another client. The international biopharmaceutical company AbbVie, which is involved in the research and development of new medications, has moved from its former office on Evropská Street to 1,600 sq m of HB Reavis’ scheme, located in Prague 5. After the recent record-breaking lease of 24 900 sq m to SAP, the Metronom building is now more than 90 percent occupied.AbbVie originated in 2013 as a spin-off of Abbott Laboratories. It uses cutting-edge biotechnology and years of professional experience to research and develop modern medicines that help to solve the world’s most serious diseases. Together with its subsidiary Pharmacyclics it employs approximately 28 000 people across the world and sells medicines in more than 170 countries.